TD Cowen Out Positive on Relay Therapeutics (RLAY), Shares Up ~53%, 'we are constructive on Ph3 success based on today's data'
TD Cowen analyst Yaron Werber reiterated a Buy rating on Relay Therapeutics (NASDAQ: RLAY).The analyst comments "Our Take: RLY-2608 Impresses ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)